JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVA
1526
DELISTED
PENN VIRGINIA CORP
PVA
| $15.4M | ﹤0.01% |
3,514,992
+3,443,625
| +4,825% | +$19.5M |
|
1527
Royal Gold
RGLD
$19.8B
| $15.4M | ﹤0.01% |
249,606
-137,013
| -35% | -$8.78M |
|
|
DD
1528
CALL
DELISTED
Du Pont De Nemours E I
DD
| $15.3M | ﹤0.01% |
252,509
-6,529
| -3% | -$440K |
|
1529
Hanover Insurance
THG
$7.73B
| $15.3M | ﹤0.01% |
207,017
+12,811
| +7% | +$920K |
|
1530
B2Gold
BTG
$6.71B
| $15.3M | ﹤0.01% |
10,015,316
+405,710
| +4% | +$658K |
|
|
BRCM
1531
CALL
DELISTED
BROADCOM CORP CL-A
BRCM
| $15.3M | ﹤0.01% |
+297,500
| New | +$14.5M |
|
1532
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $15.3M | ﹤0.01% |
30,000
| – | – |
|
|
CLNY
1533
DELISTED
Colony Capital, Inc.
CLNY
| $15.3M | ﹤0.01% |
675,166
+316,717
| +88% | +$8.05M |
|
1534
Stride
LRN
$3.29B
| $15.2M | ﹤0.01% |
1,202,675
+496,882
| +70% | +$7.4M |
|
|
RBS.PRS.CL
1535
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $15.2M | ﹤0.01% |
610,000
+169,065
| +38% | +$4.23M |
|
1536
PUT
Palo Alto Networks
PANW
$313B
| $15.2M | ﹤0.01% |
+522,000
| New | +$13.9M |
|
1537
Madison Square Garden
MSGS
$9.47B
| $15.2M | ﹤0.01% |
255,156
-98,455
| -28% | -$5.9M |
|
1538
Hyster-Yale Materials Handling
HY
$619M
| $15.2M | ﹤0.01% |
219,302
+1,442
| +0.7% | +$105K |
|
|
AGN
1539
CALL
DELISTED
Allergan plc
AGN
| $15.2M | ﹤0.01% |
50,000
-318,900
| -86% | -$95.1M |
|
|
AMAG
1540
DELISTED
AMAG Pharmaceuticals
AMAG
| $15.1M | ﹤0.01% |
219,133
+2,344
| +1% | +$147K |
|
|
TSNU
1541
DELISTED
Tyson Foods, Inc.
TSNU
| $15.1M | ﹤0.01% |
293,101
+27,463
| +10% | +$1.39M |
|
1542
Pacira BioSciences
PCRX
$972M
| $15.1M | ﹤0.01% |
213,047
+124,772
| +141% | +$9.83M |
|
|
LLTC
1543
DELISTED
Linear Technology Corp
LLTC
| $15.1M | ﹤0.01% |
340,398
+115,768
| +52% | +$5.38M |
|
1544
PUT
RTX Corp
RTX
$302B
| $15M | ﹤0.01% |
215,310
+110,277
| +105% | +$8.09M |
|
1545
Sumitomo Mitsui Financial
SMFG
$160B
| $15M | ﹤0.01% |
1,689,456
-1,039,928
| -38% | -$9.03M |
|
1546
Boyd Gaming
BYD
$5.99B
| $15M | ﹤0.01% |
1,002,795
-70,512
| -7% | -$996K |
|
1547
VSE Corp
VSEC
$6.8B
| $15M | ﹤0.01% |
560,090
-16,800
| -3% | -$558K |
|
1548
DXP Enterprises
DXPE
$3.02B
| $14.9M | ﹤0.01% |
320,426
+124,597
| +64% | +$5.52M |
|
|
K
1549
DELISTED
Kellanova
K
| $14.8M | ﹤0.01% |
251,936
-26,505
| -10% | -$1.58M |
|
1550
Helmerich & Payne
HP
$4.25B
| $14.8M | ﹤0.01% |
210,361
-97,855
| -32% | -$7.23M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.